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Abstract 
 
Micronutrients are essential for both physical and mental health. There is a correlation 
between poor health and mood and micronutrient deficiencies. Young adults age 18-24 are an at-
risk, understudied population likely to benefit from multivitamin mineral supplementation. 
Multivitamin mineral supplementation is a potential way to bridge gaps in micronutrient levels, 
thus influencing health-related outcomes. Here, we provide the first attempt at influencing 
health-related quality of life and physical activity with a multivitamin mineral supplement in 
young adults. Using a supplement formulated without herbal extracts and caffeine, this double-
blind study examined the efficacy of a daily multivitamin mineral supplement for 30 days on 
health-related quality of life and physical activity in young adults age 18-24 years. With obesity 
being a continued health concern and related to poor mental health, we also compared the effects 
in both healthy and excess body weight participants. While there were main group effects, there 
were no effects on health-related quality of life or physical activity when comparing between 
supplement and placebo group. While it is possible that supplementation may not have an 
influence on these outcomes, it is possible that low sample size or short study duration, among 
others, limited ability to more fully assess if there is an effect.  
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 1 
Overview 
Micronutrients are nutrients in the human diet that are required in very small amounts: 
the vitamins and minerals. All vitamins and minerals act as regulators and assist in all body 
processes to maintain life1. Poor health and mood have been associated with micronutrient 
deficiencies 2. This poor psychosocial health, including depression, low self-esteem, peer 
victimization, and poor quality of life, correlates with excess weight3. 
Obesity is a continued and growing health concern. The Centers for Disease Control and 
Prevention defines obesity as weight that is higher than what is considered as a healthy weight 
for a given height using Body Mass Index, BMI, to measure. BMI is a person’s weight in 
kilograms divided by height in meters squared. Persons with a BMI of 18.5-24.9 are categorized 
as healthy or normal BMI. Overweight individuals are those with a BMI of 25.0 to 29.9 and 
obese individuals are those with a BMI of 30.0 or higher4. Nationwide, rates of obesity are high, 
and Arkansas ranks in the top 10 states for adolescent and adult obesity. Approximately 22 
percent of adolescents and 35 percent of adults in Arkansas are obese. Arkansas also ranks in the 
top 10 for many obesity-related health outcomes including diabetes, hypertension, and mental 
distress 5.  
While there is a known correlation between poor health and micronutrient deficiencies, 
previous studies examining supplementation on mood have yielded mixed results. The mixed 
results are likely due to methodological reasons including varied contents of multivitamin 
supplements, absence of weight, and varied age ranges and developmental stages. There is also a 
gap in research on whether multivitamin-mineral supplementation improves health-related 
quality of life and engagement in physical activity due to improvement in mood.  
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Micronutrients 
 
Biochemical processes in the brain affect mood. Minor deficiencies in micronutrients 
could negatively influence psychological parameters. These parameters, including aggression, 
antisocial behavior, inattention, and depression, all likely related to health-related quality of life, 
are likely to be the first to benefit from supplementation6. The known roles and nutritional 
biochemistry of various micronutrients provides explanations for these associations.  
B vitamins including B6 (pyridoxine), folate, and B12 (cobalamin), play a considerable 
role in brain function and cognition7. They have many functions in the body, but most 
importantly they influence homocysteine levels throughout the body and assist in formation of 
certain neurotransmitters 7. Homocysteine is a sulfur-containing amino acid which elevated 
plasma or serum levels were once considered a marker for impaired methylation cycle and are 
now implicated in human disease in its own right7. It is produced exclusively from the 
methylation cycle and is not available from dietary sources. Folate, vitamin B12, and the active 
form of vitamin B6 (pyridoxal phosphate) are required for methylation of homocysteine. The 
possible ways in which deficiencies of B6, folate, and B12 could impair brain function and 
increase mental health risk are multiple; however, most mechanisms are related to the 
associations with homocysteine7. There are reported associations between lowered B vitamins 
and/or elevated plasma homocysteine and cognitive decline. Also, lowered B6, folate, and B12 
and elevated homocysteine have been associated with increased depression7.  
B vitamins are required for the effective production of neurotransmitters serotonin, 
epinephrine, and dopamine7. Vitamin B12 and folate influence serotonin activity. Serotonin is one 
of the most important neurotransmitters influencing mental health8. It relays signals between 
neurons, regulating their intensity. Low homocysteine is also needed for serotonin to function 
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explained through complex biochemical processes9. Epinephrine, more commonly known as 
adrenaline, has different functions on the body including increasing blood sugar levels, 
increasing heart rate, increasing contractility, and relaxation of smooth muscle in the airways to 
improve breathing. In similar ways to serotonin, homocysteine influences epinephrine 
production. Lastly, dopamine is a critical modulator of both learning and motivation10. B 
vitamins effect on homocysteine also modulates the production of dopamine7. Each of these 
neurotransmitters play a role in brain function, therefore, in mood. Each of these vitamins have 
the potential to influence mental health and deficiency of B vitamins can lead to decreased 
production of these neurotransmitters7.  
Minerals such as zinc, magnesium, calcium, and selenium may similarly impact mood 
due to their influence on neurotransmitters1. Zinc is required for many physiological processes 
such as cell proliferation and differentiation, nuclear acid metabolism, growth and development, 
and enzymatic activity regulation11. Magnesium regulates a number of biochemical processes 
and influences the functioning of the majority of the organs. It also plays a vital modulatory role 
in brain biochemistry, influencing several neurotransmission pathways associated with the 
development of depression12. Calcium is a universal messenger of extracellular signals and it 
regulates neurotransmitter synthesis and release13. Finally, selenium plays a role in brain function 
by providing antioxidant protection, having a relation to neurotransmission pathways, and 
neuron signaling14.  
Lastly, oxidative stress may affect the brain in ways that contribute to mental health 
issues such as depression and anxiety. While oxygen is essential for aerobic life, excessive 
amounts of its free radical metabolic by-products are toxic, causing oxidative stress. Keeping 
oxygen levels as low as possible in the brain is needed to defend against oxidative stress15. 
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Minerals such as selenium, copper, manganese, and zinc act as cofactors for enzymes that 
prevent oxidative stress damage7. Enzymes that prevent damage from oxidation require these 
dietary minerals. Antioxidants are compounds that protect other compounds from damaging 
reactions involving oxygen by themselves reacting to oxygen. Antioxidants act as a defense to 
free radicals by inhibiting oxidation16. Oxidation is a potentially damaging effect of normal cell 
chemistry involving oxygen. Vitamins A, C, and E are known antioxidants and help protect 
against oxidative stress7. Vitamin A act as antioxidants by quenching free radicals. Vitamin C 
acts by becoming oxidized itself and stopping a chain reaction. Vitamin E, along with vitamin A, 
prevent lipid peroxidation which is critical for the preservation of cellular membranes7. 
Supplementing these micronutrients together via a multivitamin-mineral supplement may be an 
effective and easy way to influence mood and health. 
 
Effects of Micronutrient Supplementation on Mood and Mental Health Measures 
 
A number of randomized placebo-controlled studies have indicated that multivitamin 
mineral supplementation (MVMS) can enhance mood and cognition, and sense of well-being2,17. 
Four of these placebo-controlled intervention studies used a supplement called Swisse Men’s (or 
Women’s) Ultivite to assess mood and overall well-being. This supplement contains nutrients 
found in typical over-the-counter supplements plus several herbal extracts. With acute exposure 
to the supplement, self-reported ratings of mood and mental stress improved18. Another study 
found that after 16 weeks of exposure to the supplement there were significant improvements in 
participants energy levels, mood, and sleep2. One study found that the Swisse Ultivite 
supplement reduced depression, anxiety, and stress and improved alertness and general daily 
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functioning in older men18, while another found no significant effects on any chorionic mood 
measures19. 
Six additional studies examined the effects of a variety of supplements, with no two 
studies using the same supplement. Three of the studies found significant improvements with 
micronutrient supplement on lowered violence and antisocial behavior in children ages 6-12 
years old20, improved depression and anxiety symptoms and quality of life in adults with 
depression21, as well as nursing home residents who showed improved symptoms of 
depression22. The other three studies reported weak to no effects on mood in children 8-14 years 
old23, misbehavior in adolescents age 13-1624, or aggressive behavior, impulsivity, and perceived 
stress in young adult men6. 
Lastly, four additional studies used Berocca, a micronutrient supplement made by Bayer. 
Berocca contains B vitamins, vitamin C, calcium, magnesium, and zinc. After various lengths of 
intervention, each of the four studies found significant improvements in mood, stress, mental 
health and vigor, mental stamina, and alertness in males age 30-5525,26, males age 18-4227, and 
adults 18-65 years old28. 
While the results of these studies collectively suggest improvement in mood and mental 
health measures with micronutrient supplementation, the majority of the studies have significant 
limitations. These limitations are due to potentially influencing variables that were not factored 
into study designs. There are also additional outcomes warranting investigation that have thus far 
been overlooked. Below, the potentially influencing variables that should be addressed or 
accounted for in any future studies related to this topic will be discussed. These variables are 
supplement characteristics, obesity, and young adulthood. After that, health-related quality of 
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life, diet quality, and physical activity will then be discussed as potential outcomes of MVMS 
meriting examination. 
 
Influence of Supplement Composition 
 
Ingredients of a supplement determine its potential function. One of the major limiting 
variables previously overlooked is the ingredients used and amounts of supplements provided to 
participants. The supplements in the studies mentioned were not all the same and some included 
herbal extracts2,17-19. Herbal extracts are widely known to play a role in different aspects of 
cognition. Multiple studies29 have found that herbal extracts play a positive role in depression 
and anxiety, thus they have the potential to confound or mask results from the micronutrients 
being simultaneously supplemented.  
Of the studies that used a typical MVMS, the dosage between studies was not the same. 
One study in particular tested a supplement with extremely high values of particular B 
vitamins21, while others used moderate amounts. It is difficult to adequately compare studies and 
results when the doses of micronutrients vary so widely. Therefore, future studies should 
consider using micronutrient compositions similar to those of previous studies with quality study 
designs.  
 
Influence of Obesity 
 
The obesity epidemic presents many challenges to health and chronic disease prevention 
across the lifespan. Many public health efforts are aimed at reducing obesity rates nationwide. 
The prevalence of obesity among U.S. adults is almost 40 percent, affecting nearly 93.3 million 
adults30. In Arkansas, obesity affects around 698,000 adults5. National trends suggest that excess 
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weight in pediatric populations persists into adulthood31. These rates are troubling given that 
excess weight is associated with a variety of poor physical and mental health outcomes. Physical 
health outcomes associated with obesity include diabetes, cardiovascular disease, sleep apnea, 
and cancer32. Psychologically, excess weight is associated with higher rates of depression, low 
self-esteem, peer victimization and poor quality of life3. Each of these qualities potentially relate 
back to diet and micronutrient status. 
Overweight or obese individuals are more likely to have low serum levels of various 
micronutrients than their normal weight counterparts33. These individuals typically consume 
adequate total energy, so low micronutrient levels may result from inadequate nutrient intake in 
the diet. Aspects of being overweight or obese have also been shown to alter the absorption, 
distribution, metabolism, and/or excretion of micronutrients33. Thus, multivitamin-mineral 
supplementation may be of particular potential benefit to overweight and obese individuals. 
Despite the known relationship between obesity and mental health, the previous studies related to 
MVMS and mood neglected to factor in weight as a variable. Future studies should therefore 
consider weight and BMI as variables of interest.  
 
Influence of Young Adulthood 
 
Another limitation of the previously mentioned studies is that different developmental 
stages were not factored in. There is a noticeable broad age range across studies19,21,25-28. 
However, adulthood is broken down into distinct developmental periods, each presenting with 
unique health challenges including changes in psychological, emotional, and physical 
development34. Young adulthood represents a unique developmental time in the lifespan. Young 
adults are those ages 18 to 24. The process of becoming an adult is more gradual and varied 
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today than in the past. Developmentally, this age group is leaving home and developing 
independence in decision-making35. Adult responsibilities, such as financial independence and 
residential and employment stability are still in flux at this stage. This is also a critical time for 
identity development. As young adults move out of the home and begin exploring new 
behaviors, they make choices which shape them into the person they want to become. Young 
adults make choices that have the potential to impact lifelong behavioral patterns. Compared to 
adolescents, young adults have worse health in multiple areas and many high-risk behaviors peak 
during this time. For example, rates of obesity, depression and suicide, and alcohol use are all 
greater during this time compared to adolescents36. Overall, the transition from adolescence to 
adulthood is marked with risk of excess weight gain. As obesity increases in this time period, so 
do the comorbid psychological and physical impairments. 
Also, age and life-stage have previously been demonstrated to alter nutrient absorption37. 
Recommended nutrient intakes also change throughout the lifespan. Young adults are an 
overlooked and understudied high-risk group. Young adults have some of the unhealthiest eating 
habits compared to other age groups38. Having a low diet quality indicates lower intakes of 
healthier items from core food groups such as fruits, vegetables, whole grains, and other key 
nutrients, and higher intakes of energy-dense, nutrient poor foods such as processed food and 
sugary beverages38. Low diet quality thereby potentially leads to inadequate micronutrient 
intakes. While college students are typically used as a convenience sample to generalize to 
populations of adults, few studies have focused solely on the health and well-being of this age 
group. With this, young adults should not be grouped with all adults over the age of 18 years, but 
rather warrant scientific focus on their age group and developmental stage, especially in relation 
to diet and mood. 
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Health-Related Quality of Life as an Outcome 
 
Increasingly, health care providers are recognizing that measures of disease alone are 
insufficient in defining health status. Quality of life has become a complementary health status 
measure. It is a broad multidimensional concept that usually includes subjective evaluations of 
both positive and negative aspects of life39. Health-related quality of life (HRQOL) has evolved 
to encompass aspects of overall quality of life that can be clearly shown to affect health. The 
CDC has defined HRQOL as an individual’s or group’s perceived physical and mental health 
over time40. They created four highly validated HRQOL items, the first focusing on self-
perceived health. The second and third items relate to recent physical and mental health 
symptoms and are considered mutually exclusive and are worded as such. The fourth item is 
conceptualized as a global measure of disability that incorporates both physical and mental 
health. The CDC HRQOL questionnaire is as follows:  
1. In general, how would you rate your health?  
2. Now thinking about your physical health, for how many days during the past 30 days 
was your physical health not good?  
3. Now thinking about your mental health, for how many days during the past 30 days 
was your mental health not good?  
4. During the past 30 days, on how many days did poor physical or mental health keep 
you from doing your usual activities, such as self-care, work, recreation?  
 
While some studies have explored the relationship between micronutrients and overall 
quality of life, only one has focused on micronutrients and HRQOL. This recent study found a 
negative impact of vitamin D deficiency on HRQOL when exploring the extent to which 
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micronutrient deficiencies affect children’s HRQOL, using vitamin D deficiency as a case 
study41. With the current gap in literature and an effective HRQOL tool available, there is an 
opportunity to explore the relationship between micronutrient status and health-related quality of 
life. Careful considerations in study design that were overlooked in the previously mentioned 
MVMS studies should also be considered including weight, age, and exercise. 
 
Physical Activity as an Outcome 
 
Macronutrients including proteins, carbohydrates, and fat provide sources of energy 
needed to fuel the body and provide structure to perform work. Micronutrients enable the use of 
macronutrients for all physiological process. Vitamins and minerals are key regulators of health 
and function which includes work performance42. Previous studies have explored if MVMS can 
enhance health and sports performance,43 but not if MVMS use or micronutrient status can 
influence frequency of exercise.  Micronutrient deficiencies may play a role in frequency of 
physical activity. 
There is a growing body of literature that recognizes the positive effects of physical 
activity on mood44. Exercise can improve anxiety, stress, depression, and psychological 
functions. Contrarily, studies show consistent negative associations between mental health and 
sedentary behavior, or physical inactivity45. While there are known positive effects of physical 
activity, a large proportion of those with mood and/or anxiety disorders do not exercise 
regularly46. Indicated barriers to physical activity include physical conditions, time constraints, 
and lack of will power/self-discipline, most of which relate back mood. Studies suggest that one 
of the main reasons people take multivitamins is to increase both physical and mental energy47. 
Since physical activity and inactivity corelate with aspects of mental health, MVMS could result 
in more physical activity by which enhancing mood and mental health indicators. 
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Summary and Objectives 
 
Micronutrients are essential to health and well-being, both physical and mental. Several 
micronutrients are involved with biochemical processes in the brain. MVMS is a potential way to 
bridge gaps in micronutrient intake, thus potentially influencing other health-related outcomes. 
While there are many previous studies related to MVMS and mood/mental health measures, 
there are key considerations in study design that were overlooked and need to be factored into 
future related studies. When looking at effects of micronutrient supplementation on the brain, 
care should be taken to choose a supplement that excludes herbal extracts and caffeine due to 
their potential to alter brain function. Further, having excess weight or being a young adult may 
uniquely contribute to risk of alterations in mood and mental health, and thus may contribute 
greater response to interventions. Lastly, there is reason to suspect that MVMS may favorably 
influence overall health-related quality of life and engagement in physical activity.    
 Using a supplement patterned after the Berocca studies that is void of herbal extracts and 
caffeine, we will examine the efficacy of daily MVMS use on health-related quality of life and 
physical activity in young adults (18 – 24 years old). Moreover, we will compare whether effects 
are greater in those with excess body weight. We hypothesize that supplementation over a 30-
day period will improve these measures, and more so in overweight/obese young adults.   
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Methods 
Recruitment/Participants 
 
Participants were recruited from a mid-south public university via campus flyers, 
postings in a digital campus news source, and through classroom announcements. Initial 
eligibility was determined by a scripted phone call by study staff. Inclusion criteria were 18 to 24 
years old; healthy or overweight/obese BMI; going to school or working part time; ability to 
swallow pills; no malabsorption; no gastrointestinal diagnosis, impaired liver/renal function; no 
iron deficiency anemia; not taking prescriptions for a mental health diagnosis; and willing to 
abstain from taking other drugs and herbal supplements for the duration of the study. Final 
eligibility was confirmed during the informed consent process, which included training and 
familiarization of participants with the study protocol. Demographic information was collected, 
and baseline assessments completed immediately after participants completed the informed 
consent process. The demographic and baseline assessments included age, BMI, health 
indicators, and nutritional status. A total of 137 men and women aged 18-24 years were 
randomized and completed this controlled trial. Of the participants, 72 were of healthy BMI 
(18.5-24.9) and 65 were overweight/obese BMI (25+). This study was approved by the 
University of Arkansas Institutional Review Board for human subject research (Approval 
#1709073942).  
 
Randomization and Study Design 
 
Participants were randomized to receive either a placebo or a multivitamin mineral 
supplement in identical pill form. Study participants were divided by chance into separate pill 
groups. Groups were randomized using a random sequence generator. Participants took two pills 
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every morning for 30 days. Participants were required to come to the study office every week to 
return all unused pills, pick up a week’s supply of their designated pill, and to collect 
compensation as applicable. Compliance was assessed weekly via pill counting. Participants had 
two assessment days on Day 0 and Day 30. On these days they completed self-administered 
online questionnaires. The amounts of micronutrients in the multivitamin mineral supplement 
were similar to the Berocca® supplement and are listed in Table 1. 
Table 1. Composition of MVM Supplement 
Vitamin/Mineral Amount in 
Supplement 
RDA %RDA 
B1 = Thiamin 15 mg 1.1 – 1.2 mg 1364 
B2 = Riboflavin 15 mg 1.1 – 1.3 mg 1364 
B3 = Nicotinamide 50 mg 14 – 16 mg 357 
B5 = Pantothenic 
Acid 
23 mg 5 mg 460 
B6 10 mg 1.3 mg 769 
B12 10 µg 2.4 µg 416 
C 500 mg 75 – 90 µg 667 
H = Biotin 150 µg 30 µg 500 
Folic Acid 400 µg 400 µg 100 
Calcium 100 mg 1,000 mg 10 
Magnesium 100 mg 310 – 400 mg 32 
Zinc 10 mg 8 – 11 mg 125 
 
Questionnaires 
 
Participants completed self-administered online assessments at baseline and at the end of 
the 30-day study protocol. Questionnaires assessed health indicators, including health-related 
quality of life, exercise, and nutrient intake for diet quality. Assessments were a compilation of 
validated and accepted instruments presented randomly through a Qualtrics survey. The CDC’s 
Health Related Quality of Life-14 Measure (HRQOL) was used to assess multiple dimensions 
related to physical, emotional, and social functioning. HRQOL increasingly has been 
acknowledged as a valid health indicator and measures physical functioning, psychological well-
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being, social and role functioning and health perceptions40. The International Physical Activity 
Questionnaire (IPAQ) is the most widely used physical activity questionnaire48. It is a 4-item 
measure of health-related physical activity.  Subjects were reminded to complete the assessments 
via text and email. Participants received a total of $100 in cash for completing the study. 
Compensation was distributed incrementally as participants progressed through though the study 
to further encourage completion of the study.  
 
Statistical Analysis 
 
First, descriptive statistics were conducted on the full sample. Next, a split-plot analysis 
of variance (ANOVA) was conducted to detect both main effects as well as interaction effects 
between the control group (placebo pill) and the intervention group (MVMS) at time 1 (baseline) 
and time 2 (follow up day 30). Dependent variables included four health-related quality of life 
(HRQOL) variables which include the number of physical unhealthy days, number of mentally 
unhealthy days, the number of physically and mentally unhealthy days (combined), and the 
number of days where health was a limited factor (all coded 0 to 30).  Physical activity was also 
used as a continuous dependent variable. Next, further analyses were conducted by BMI group 
by conducting the same split-plot ANOVA using the normal weight sample, and the overweight 
sample, respectively. Analyses were conducted using SPSS, v2649 49.  
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Results 
 
Participant Characteristics 
 
The study had a total of 154 participants at baseline. After excluding dropouts and those 
with compliance issues, 137 participants were included for data analysis. Of the 137 participants, 
67 received placebo and 70 received the supplement (Table 2). The majority of participants were 
undergraduate or graduate students, living in an urban area, with some college completed, and 
employed part-time. The study consisted of 107 females (49 received placebo and 58 received 
the supplement) and 34 males (18 received placebo and 12 received the supplement). Student 
status was similar between the two groups with the exception of the supplement group having 
more seniors than the placebo group. The majority of participants in both groups lived in urban 
geographic locations.  
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Table 2. Participant Characteristics 
 
Placebo 
(N=67) 
MVMS 
(N=70) 
Females 49 (73.1%) 58 (82.9%) 
Males 18 (26.9%) 12 (17.1%) 
BMI 
  
     Normal (18.5-24.9) 35 (52.2%) 37 (52.9%) 
     Overweight/obese (>25) 32 (47.8%) 33 (47.1%)  
Age (Average ± SD) 21 yrs ± 1.76 20 yrs ± 1.79 
Student Status 
  
     Non-Student 2 (3.0%) 3 (4.3%) 
     Freshman 10 (14.9%) 9 (12.9%) 
     Sophomore 18 (26.7%) 15 (21.4%) 
     Junior 15 (22.4%) 11 (15.7%) 
     Senior 12 (17.9%) 25 (35.7%) 
     Grad Student 10 (14.9%) 7 (10%) 
Geographic living location  
  
     Rural 6 (9.0%) 11 (15.7%) 
     Urban 61 (91.0%) 59 (84.3%) 
Level of Education Completed 
  
     Some high school - 1 (1.4%) 
     High school 9 (13.4%) 17 (24.3%) 
     Some college 42 (62.7%) 38 (54.3%) 
     Associate degree 2 (3.0%) 4 (5.71%) 
     Bachelor’s degree 12 (17.9%) 10 (14.3%) 
     Post-graduate degree  2 (3.0%) - 
Employment Status 
  
     Unemployed 21 (31.3%) 20 (28.6%) 
     Part-time 40 (59.7%) 46 (65.7%) 
     Full-time 6 (9.0%) 4 (5.7%) 
 
HRQOL 
 
When examining the results of the split-plot ANOVA, two key results will be 
investigated.  First, “main effects” are overall trends of all participants, regardless of whether or 
not each individual was in the control or intervention group (i.e., a standard repeated measures 
ANOVA) to determine if there was an overall change between baseline and time 2.  Next, 
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“interaction effects” were investigated in order to determine if there were differences between 
individuals when partitioned into their respective control or intervention groups.  In other words, 
a significant interaction term of less than .05 would determine if group membership in the 
intervention group had a statistically significant difference when compared to individuals in the 
control group.  
 Main effects and interaction effects will be investigated in three different contexts.  The 
first is using all individuals (main effects) and their control or intervention group (interaction 
effects).  The second is looking at main and interaction effects using only those in the healthy 
BMI group, and the third is using only those in the unhealthy BMI group. 
 Physically Unhealthy Days. The results of split-plot ANOVA interaction for each 
HRQOL variable, excluding BMI, are presented in Figure 1. Though both groups showed 
descriptive decreases in the number of unhealthy days (the control group had a net decrease of 
.75 days while the intervention group had a net decrease of .43), no main effects were detected 
(F= 1.187, p= .278, R2= .01; that is, regardless of the intervention). With respect to differences 
by group (control versus intervention), no interaction effects were present (F= .090, p= .765, R2= 
.001), indicating no effects as a result of the intervention.  
Regarding BMI, for  the healthy weight group, both the control group and intervention 
group decreased in the number of physically unhealthy days (net decreases of .94 and 1.94 days, 
respectively), yet this was only a trend for an overall decrease (main effects: F= 2.930, p= .09, 
R2= .04).  The interaction was also not statistically significant (F= .144, p= .519, R2= .002). For 
the overweight group, the control group had a net decrease of .56 days, while the intervention 
group had an increase of .62 days.  No main effects (F= .001, p= .973, R2< .001) or interactions 
(F= .519, p= .706, R2= .002) were detected. 
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Mental Unhealthy Days. Mental Unhealthy Days is also represented in Figure 1. Similar 
to Physically Unhealthy Days, there was no interaction effect by group (F=.029, p=.866, 
R2=<.001). However, there were statistically significant main effects detected (F=26.235, 
p=.000, R2=.168), regardless of intervention.  
When factoring in BMI for mental unhealthy days, all participants showed statistically 
significant improvement (main effects: F=12.579, p=.001, R2=.164 and F=13.345, p=.001, 
R2=.173, respectively). Both the control and intervention group for the healthy BMI saw no 
interaction effects were detected (F=.002, p=.969, R2=.000). Similarly, the overweight BMI 
group saw no interaction effects between the control and intervention groups (F=.067, p=.796, 
R2=.001). 
Physical and Mental Unhealthy Days Combined. The results of split-plot ANOVA 
interaction for number of physically and mental unhealthy days combined are shown in Figure 1.  
Both groups showed descriptive decreases in the number of combined days (the control group 
had a net decrease of 2.69 days while the intervention group had a net decrease of 2.21), and 
statistically significant main effects were detected (F= 14.895, p=.000, R2= .103; that is, 
regardless of the intervention). With respect to differences by group (control versus 
intervention), no interaction effect was present (F= .018, p= .893, R2= .000), indicating no effects 
as a result of the intervention.  
For physical and mental unhealthy days combined, all participants showed significant 
improvement with significant main effects (F=11.529, p=.001, R2=.153 for the healthy weight 
and F=5.627, p=.021, R2=.081 for the overweight group). However, no effects were detected for 
either healthy BMI (F=1.246, p=.268, R2=.019) or overweight BMI (F=.328, p=.569, R2=.005) in 
regard to interaction between control and intervention. 
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Health Limitation Days. Lastly, also presented in Figure 1 are the results of split-plot 
ANOVA interaction for number of health limitation days. Both placebo and MVMS groups 
showed descriptive decreases in the number of combined days (the control group had a net 
decrease of .95 days while the intervention group had a net decrease of 2.21) and statistically 
significant main effects were detected (F= 14.7756 p=.000, R2=.101; that is, regardless of the 
intervention). With respect to differences by group (control versus intervention), no interaction 
effects were present (F= 2.317, p= .130, R2= .017), indicating no effects as a result of the 
intervention.  
Regarding BMI for health limitation days, for the healthy BMI group, main effects were 
detected (F=15.884, p=.000, R2=.199), however, no statistical significance was found between 
the control and intervention groups (F=1.596, p=.211, R2=.024). The overweight BMI group 
showed no main or interaction effects present (F=3.609, p=.062, R2=.053 and F=.950, p=.333, 
R2=.014, respectively) also indicating no effects as a result of the intervention. 
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Figure 1. HRQOL Split-Plot ANOVA Interactions 
 
Physical Activity 
 
The results of split-plot ANOVA interaction for physical activity are shown in Figure 2. 
There was no difference in physical activity between the placebo and MVMS after the 30-day 
study (F=.803, p=.372, R2=.006). There also were no main effects detected for physical activity 
(F=1.562 p=.214, R2=.012). 
BMI did not affect the results of physical activity. There were no statistically significant 
results for the healthy BMI group main effects (F=1.424, p=.237, R2=.022) or between the 
control and intervention groups (F=.805, p=.373, R2=.012). As for the overweight BMI group, no 
results were detected for main effects (F=.370, p=.545, R2=.006) or interaction effects (F=.161, 
p=.690, R2=.003). 
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Figure 2. Physical Activity Split-Plot ANOVA Interactions 
 
Discussion 
 
Overall, there was greater improvement in the MVMS group than the placebo group 
numerically, but the differences did not reach statistical significance. There were no statistically 
significant differences between the placebo and MVMS groups for any of the variables; 
however, there were instances of statistical significance regarding main effects, regardless of the 
intervention. When factoring in BMI, results for outputs were similar to overall results 
suggesting that weight and/or BMI is not a factor for HRQOL or physical activity being 
influenced by MVMS.   
The lack of statistical significance between placebo and MVMS groups could be due to a 
variety of reasons, one main reason being small sample size. While the study had a large sample 
size to begin with, the number of participants with adequate or complete data was lower. A small 
sample size could result in lower power and a greater chance of a Type II error. Our sample size 
potentially was not powered high enough. This issue of sample size also relates to participant 
compliance. Compliance issues with participants were multiple and resulted in some participants 
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not being in included in data analyses; this could have further decreased the ability to accurately 
assess the effects of the MVMS.  
To our knowledge, this was the first attempt using a MVMS to potentially influence 
HRQOL. The most relevant previous study only looked at deficiency of a single micronutrient, 
not the influence of a multivitamin mineral supplement. Assessing participants’ micronutrient 
status could have determined if a supplement was needed. Moreover, those lacking initially in 
micronutrients could have been those that we saw improvements in. It could be that MVMS does 
influence HRQOL if micronutrient levels are low enough to begin with. Having diet quality as a 
variable could have been useful in determining this information. Diet quality is a term that is 
often used in nutritional epidemiology to evaluate the population’s dietary habits and the efficacy 
of dietary interventions50. Different diet quality methods have proved to be useful indicators of 
micronutrient content in the diet51. MVMS are used to supplement and improve diet quality. 
However, adequate nutrient intake can usually be achieved through a well-balanced diet and 
supplementation may not confer additional health benefits52. Diet quality can often be poorly 
defined and hard to measure. However, one approach has been developed and frequently used in 
the literature to define diet quality and that is the Healthy Eating Index (HEI). Nearly 300 
publications have used HEI to evaluate food intake and diet quality53. Developed by the USDA 
Food and Nutrition Service, HEI is used to assess how well a set of foods aligns with key 
recommendations of the Dietary Guidelines for Americans. The Dietary Guidelines for 
Americans (DGA) is designed for nutrition and health professionals to help individuals consume 
a healthful and nutritionally adequate diet. 
Alternatively, or in addition to diet quality, biochemical levels of micronutrients would 
be useful in determining if the supplement provided benefit. A blood draw at baseline and day 30 
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for biochemical assessment of thiamin and riboflavin [spectrophotometric functional assays 
using red blood cells54, vitamin B6 (plasma pyridoxal-5-phosphate by High Performance Liquid 
Chromatography (HPLC)55, vitamin B12 (plasma by ELISA kit), vitamin C (plasma ascorbic 
acid by commercial ELISA kit), folate (serum by commercial ELISA kit), vitamin D (serum 25-
hydroxy-vitamin D by HPLC56), and iron status (whole blood hemoglobin 
spectrophotometrically57, zinc protoporphyrin by hematofluorometer, plasma ferritin by 
commercial ELISA kit). Although not supplemented, assessment of vitamin D and iron status 
should be taken due to their known role in cognition that are independent of the supplemented 
micronutrients. Biochemical assessment of niacin, pantothenic acid, and biotin are lacking 
consensus on the appropriate analytical method. Magnesium and zinc are not mentioned here for 
biochemical assessment because plasma magnesium levels can remain normal during deficiency, 
and zinc levels only drop in extreme deficiency.   
 Time could also play a role in the findings from this study. While most variables were 
not different between the two groups, the study did find slight results. MVMS could potentially 
take longer than 30 days to influence HRQOL and physical activity. Similarly, age could 
influence the findings. We chose to focus on young adults for a variety of reasons; however, a 
MVMS may not influence young adults as expected. 
The lack of finding a difference between the two groups could also be due to a placebo 
effect, placebo effect being the participants’ belief in the treatment producing results that cannot 
be attributed to the placebo itself 58. The act of taking a daily pill and the knowledge of what the 
study was looking at could have made the participants think their health was improving and 
narrowed the difference at the Day 30 assessment. Alternatively, there may be no true effect 
from the MVMS. 
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There was no difference in physical activity between the two groups. This could be due to 
the way the questionnaire was worded. Participants were to enter how many hours of different 
exercise was performed, followed by how many minutes of exercise was performed. There were 
multiple instances that participants entered very different or drastic answers for the two 
questions. For instance, one participant entered that they performed 300 hours of exercise. 
Because of these inconsistencies, the outliers were left blank. This affected the person’s overall 
physical activity score as well as the overall data for the group.   
 
Strengths and Limitations 
 
This study has numerous strengths mostly relating to study design. The close 
consideration in developmental period and detailed inclusion criteria were strong choices which 
enhanced the quality of the study. Also strengthening our study was the supplement used because 
it contained only vitamins and minerals and excluded herbal extracts and caffeine. The study also 
used high quality methods to measure study endpoints; all questionnaires used were previously 
validated and are widely accepted. 
Nonetheless, this study was not without its limitations. While the questionnaires used 
were all of high quality, they were all self-reported measures. The only measure not self-reported 
was BMI. Another limitation was participant compliance. The study team had measures in place 
to encourage compliance, but participants could have forgotten to take pills but still reported that 
they did. A blood or urine sample collected at baseline and day 30 may have helped accurately 
assess compliance with pill intake. Another limitation is the small sample size with limited 
generalizability, particularly with such small numbers of males participating, which may have 
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limited power. However, being the first study to our knowledge to assess MVMS on HRQOL 
measures and physical activity, it was difficult to determine the target sample size. 
 
Conclusion 
 
 MVMS did not influence HRQOL measures or physical activity over a 30-day study 
period. However, these measures were influenced, regardless of intervention, perhaps due to a 
placebo effect. Whether methodological effects or placebo effect were at play, these finding lend 
themselves to future studies. A multivitamin mineral supplement could still be beneficial to 
young adults of both healthy and overweight/obese BMI. The quality of this study was high due 
to study design and justification. Although no effect from the supplement was observed, future 
research should examine this topic further. Since this study was the first of its kind, there could 
be methodological differences that lead to truer assessment of the relationship. Future studies of 
the effects of MVMS on HRQOL measures and physical activity should include assessment 
serum nutrient levels and diet quality. Also, assessment of supplementation for longer than 30 
days with a larger sample size is warranted.  
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Study Recruitment Flyer 
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Appendix B 
 
Participant Screening Script and Questionnaire  
Hello, my name is ___ and I am a research assistant with the Multivitamin-Mineral 
Supplementation study at the University of Arkansas. Is now a good time to talk and give you 
some information about the study? (If yes, say thank you and continue on. If no, then ask if there 
is a better time to call back).  
  
Thank you very much for your interest in our study. First, I would like to tell you a little about 
the study and if you are interested then ask you a few questions to determine if you are eligible to 
participate.   
  
This research study is looking at the effects of multivitamin-mineral supplementation on mood 
and overall well-being. Participants in this study will be asked to take a daily multivitamin 
supplement or placebo for 30 days and complete online questionnaires asking about mood, 
physical health and diet, and weight-related health. Your participation would last approximately 
32 days and you would be compensated $100 for participating.      
  
Are you still interested? (If they are not interested in participating: Thank you for your time and 
interest in the study.)  
  
If yes: Great! We are happy to hear you are interested in participating. We have a few screening 
questions that we would like to ask to determine your eligibility in the study. These questions ask 
your basic information and if you have any health-related diagnoses that could possibly impair 
the effectiveness of the multivitamin supplementation. Do I have your permission to ask these 
questions?  
Note to research assistants: Please go through the entire screening questionnaire even if they 
are disqualified half way through.    
  
  
  
Screening Questionnaire  
1. What is your name?   
  
2. What is your phone number and email address?  
  
3. What is your preferred method of contact?  
  
4. What is your height?  
  
5. What is your current weight?  
  
6. BMI?  
  
7. Are you between 18 and 24 years old?    
Yes                                                                   No  
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8. Are you pregnant or planning to become pregnant? (If male, skip this question)  
Yes                                                                   No                                    N/A  
9. Are you going to school or working at least part-time?   
Yes                                                                   No  
10. Have you ever been diagnosed with malabsorption, or any related gastrointestinal 
diagnoses for example, Chron’s disease or inflammatory bowel syndrome?   
Yes                                                                   No  
11. Have you ever received a diagnosis related to impaired liver or renal function?   
Yes                                                                   No  
12. Do you have iron deficiency anemia?   
Yes                                                                   No  
13. Have you ever been diagnosed with a mental health disorder, for example, general 
anxiety, depression, bipolar disorder or an eating disorder?   
Yes                                                                   No  
14. Are you currently taking any prescription medications for a mental health diagnosis?   
Yes                                                                   No  
15. Are you willing to abstain from taking any other supplements during the study and 
abstain from taking any drugs, including marijuana?   
Yes                                                                   No  
16. Are you extremely uncomfortable or unable to swallow pills?   
Yes                                                                   No  
  
  
NOTE: People responding YES to questions 7, 9, 10, 11, 12, 13, and 15 or a NO to question 14 
are not eligible for the study.   
  
For those not eligible to participate (answering yes to any of the above disqualifies the 
person from participating): I am sorry to inform you that unfortunately you are not eligible to 
participate in the Multivitamin-Mineral Supplementation study. Thank you very much for you 
interest in participating.   
  
  
  
For those eligible to participate: You are eligible to participate in our study! Next, we would 
like for you to come to our study laboratory so that we can obtain your informed consent, explain 
the study instructions, and get some further background information from you. Our study 
laboratory is located on the 2nd floor of the Home Economic building in office 205D on the 
University of Arkansas campus. When would be a good time for you to come in? (Schedule a 
date and time).  
We appreciate your interest in the multivitamin-mineral supplementation study and we look 
forward to meeting you on (date) and (time). If you have any questions or trouble locating our 
lab, please do not hesitate to contact me at _______________.   
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Appendix C 
 
Participant Informed Consent Form 
Multivitamin-Mineral Supplementation & Mood Study 
Consent to Participate in a Research Study 
Principal Researcher: Jennifer Becnel, PhD & Sabrina Trudo, PhD, RD 
 
 
INVITATION TO PARTICIPATE 
 
You are invited to participate in a research study investigating the effects of multivitamin-
mineral supplementation on your health. You are being asked to participate in this study 
because you are between the ages of 18 and 24 years old, going to school or working at least 
part-time, and have no gastrointestinal or mental health diagnoses. Please take time to review 
the following form, ask questions, and decide whether you wish to participate or not.  
 
WHAT YOU SHOULD KNOW ABOUT THE RESEARCH STUDY 
 
Who are the Principal Researchers? 
This study is being conducted by Jennifer Becnel, PhD and Sabrina Trudo, PhD, RD of the School 
of Human Environmental Sciences at the University of Arkansas. Dr. Becnel can be reached by 
phone at 479-575-2358 or by email at becnel@uark.edu. Dr. Trudo can be reached by phone at 
479-575-4863 or by email at trudo@uark.edu. 
 
What is the purpose of this research study? 
Poor health and mood have been associated with micronutrient deficiencies. The purpose of 
this study is to examine the effects of multivitamin-mineral supplementation on mood, health, 
and weight-related satisfaction in young adults.  
 
Who will participate in this study? 
This study will include 140 young adult men and women. To participate, you must be the ages 
of 18-24, going to school or working at least part-time, have no malabsorption or related 
gastrointestinal diagnosis, no mental health diagnosis, and not taking prescription medications. 
You must be willing to take only the provided multivitamin-mineral supplement for 30 days.  
 
What am I being asked to do? 
During your first visit to the study laboratory, study staff will explain the study and address any 
questions or concerns you may have. If you agree to participate, study staff will take your 
height and weight and outline a detailed schedule for your participation in the study. You will 
also fill out a short questionnaire asking basic questions about yourself. At this time, we ask 
that you discontinue use of dietary/herbal supplements (including all vitamins and teas). 
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Participation in this study will last 31 days. You will be randomly assigned to take two pills daily 
for a month of either a multivitamin-mineral supplement or placebo (not containing any 
vitamins or minerals). You will not know if you are assigned to take the multivitamin-mineral 
supplement or the placebo. During the 31 days, you will be asked to visit the study laboratory 
weekly (every 7 days) to pick up the multivitamin-mineral supplements or placebo. The 
multivitamin-mineral supplement or placebo is to be taken every morning at approximately the 
same time. Additionally, you are asked to complete two online questionnaires on five 
assessment days: Day 1, Day 3, Day 4, Day 15, and Day 30. The first online questionnaire will ask 
questions about psychological functioning, health, and weight-related satisfaction. The second 
online questionnaire will ask about your dietary intake in the previous 24 hours. The 
questionnaires should take approximately one hour to complete, total. On the last day of the 
study, you will be asked to return to the study laboratory to have your height and weight taken 
again. Below is an outline of the study schedule.  
 
Study Schedule 
Day 0:  Return to the study laboratory to pick up the supplements/placebo. You will be 
given 7 days’ worth of the supplement/placebo.  
Day 1: Begin taking the supplement/placebo in the morning and complete the online 
assessments within 3 hours of taking the supplement/placebo. 
Day 3:  Complete the online assessments within 3 hours of taking the 
supplement/placebo.  
Day 4:  Complete online assessment before taking the supplement/placebo.  
Day 7:   Return to the study laboratory for another week’s supply of the 
supplement/placebo.  
Day 14: Return to the study laboratory for another week’s supply of the 
supplement/placebo. 
Day 15: Complete the online assessments within 3 hours of taking the 
supplement/placebo. 
Day 21: Return to the study laboratory for another week’s supply of the 
supplement/placebo. 
Day 30: Complete the online assessments within 3 hours of taking the 
supplement/placebo.  
Day 31:  Return to the study laboratory to finish out the study and have your height and 
weight taken.  
 
What are the possible risks or discomforts? 
You may feel uncomfortable answering some of the questions in the online questionnaire. If 
you feel any discomfort, you can omit an answer to a question or terminate your involvement 
in the study. You will not be penalized for omitting answers or terminating the questionnaires 
early. There may be discomfort from swallowing the supplement/placebo pills if you are not 
accustomed to swallowing pills. If you find that you cannot tolerate swallowing pills, you do not 
have to complete the study. The amounts of the vitamins and minerals in the supplement are 
similar to supplements that are available for purchase at stores. 
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What are the possible benefits of this study? 
There are no benefits to participating in the study.  
 
Will I receive compensation for my time and inconvenience if I choose to participate in this 
study? 
You will receive a total of $100 in cash for completing the study, distributed as each assessment 
day is completed. Compensation is received for each day the online questionnaires are 
completed. Amounts increase for each questionnaire day (Day 1 = $10, Day 3 = $15, Day 4 = 
$20, Day 15 = $25, Day 31 = $30). To minimize the number of times you need to visit the 
laboratory, compensation will be dispersed on Day 7, Day 21, and Day 31.  
 
Will I have to pay for anything? 
There will be no cost associated with your participation in this study.  
 
 
 
What are the options if I do not want to be in the study? 
If you do not want to be in this study, you may refuse to participate. Also, you may refuse to 
participate at any time during the study. Your standing and relationship with the University of 
Arkansas will not be affected in any way if you refuse to participate or drop out of the study. 
 
How will my confidentiality be protected? 
All information will be kept confidential to the extent allowed by applicable State and Federal 
law. Participants in this study will be assigned an ID number to ensure confidentiality. A master 
list linking participant’s names to ID numbers and all participant data will be kept on a secure 
server that only the study staff will have access to.   
 
Will I know the results of the study? 
At the conclusion of the study you will have the right to request feedback about the results. You 
may contact the Principal Researcher, Jennifer Becnel at becnel@uark.edu or 479.575.2358. 
You will receive a copy of this form for your files. 
 
What do I do if I have questions about the research study? 
You have the right to contact the Principal Researcher as listed below for any concerns that you 
may have. 
 
Jennifer Becnel, PhD 
Assistant Professor of Human Development and Family Sciences 
Human Environmental Sciences 
HOEC 118 
1 University of Arkansas 
Fayetteville, AR 72701 
479.575.2358 
Becnel@uark.edu 
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Sabrina Trudo, PhD, RD 
Associate Professor of Nutrition 
21st Century Endowed Chair in Human Environmental Sciences 
HOEC 118 
1 University of Arkansas 
Fayetteville, AR 72701 
Tel: 479.575.4863 
trudo@uark.edu 
 
 
 
 
 
 
 
You may also contact the University of Arkansas Research Compliance office listed below if you 
have questions about your rights as a participant, or to discuss any concerns about, or problems 
with the research. 
 
Ro Windwalker, CIP 
Institutional Review Board Coordinator 
Research Compliance 
University of Arkansas 
109 MLKG Building 
Fayetteville, AR  72701-1201 
479-575-2208 
irb@uark.edu 
 
 
STATEMENT OF CONSENT 
 
I have read the above statement and have been able to ask questions and express concerns, 
which have been satisfactorily responded to by the investigator. I understand the purpose of 
the study as well as the potential benefits and risks that are involved. I understand that 
participation is voluntary. I understand that no rights have been waived by signing the consent 
form. I have been given a copy of the consent form. 
 
Name of Participant: ________________________ 
 
Signature of Participant: ______________________ 
 
Signature of Investigator: _____________________ 
 
Date: ______________ 
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Appendix D 
 
Participant Instruction Booklet 
Multivitamin-Mineral 
Supplementation & Mood Study  
  
  
  
Participant Instruction Booklet  
  
  
For questions about any part of the study, please contact your study coordinator.  
Study Coordinator: Sharon Chang  
Laboratory: HOEC 205D  
Research Coordinator: ______________________  
Coordinator Phone Number: _____________________  
Emergencies—Dr. Becnel  
(480) 276-2955  
Email  
Yc031@uark.edu  
  
Please stop taking all medications and dietary/herbal supplements (including all 
vitamins and teas) beginning one week before the study period.  
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Stop on:_________________  
    
Purpose of the Study  
The primary purpose of this study is to examine the effects of a multivitamin-mineral 
supplement (MVM) on psychological functioning, health, and weight-related satisfaction among 
young adult college students.   
  
Study Procedures and Time Commitment  
This is a research study looking at the effects of Multivitamin-Mineral Supplementation on 
mood and overall well-being. The total timeline for the project is two years, during which we 
will conduct a randomized controlled trial at the University of Arkansas, Fayetteville. However, 
you are required to participate in the study only for 31-days.   
  
You may qualify for the study if you are/have:  
• 18 – 24 years old;   
• Going to school or working at least part-time;   
• No diagnosis of malabsorption or related gastrointestinal diagnoses (e.g., Crohn’s 
disease, inflammatory bowel disease);   
• No diagnosis related to impaired liver or renal function;   
• No mental health diagnosis (e.g., general anxiety disorder, depression, bipolar-related 
diagnoses);   
• Not taking prescription medications for mental health diagnoses;  
• And willing to not take any other supplements during the study.  
  
After the screening interview over the phone, if you qualify, you will be asked to come to the 
study laboratory to have your height and weight taken, fill out a one-time demographic 
questionnaire, and be given the study instructions and activities. At this time, we will randomly 
assign you to either the MVM supplement or placebo group.  The following week, you will 
return to the study laboratory to receive a week’s supply of the supplement or placebo pills and 
will be instructed to take two pills at approximately the same time every morning. You will 
return to the study laboratory once a week for another week’s supply of the supplement or 
placebo pills and to return any pills that you did not take during the previous week.   
  
You will also be asked to complete the following two questionnaires on each of the 
five assessment days: Consent Day, Day 3, Day 4, Day 15, and Day 31. They are,  
  
1. Questionnaire- I:  A self-administered online questionnaire to 
assess your psychosocial functioning, health indicators, and weight related satisfaction. It is 
a set of questionnaires that will be presented in a random order each time 
through Qualtrics software.  
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2. Questionnaire- II: A self-administered online questionnaire, ASA24®, to assess your 
dietary intake in the previous 24 hours. ASA24® is completed separately using a website and 
confidential login from the National Cancer Institute.   
  
  
You will be instructed to complete the questionnaires within three hours after taking the 
supplement or placebo on Day--3, Day 15, and Day 31. However, on Day 4 you will be required 
to complete the questionnaires before taking the supplement. Links to the questionnaires will 
be provided to you and you will be reminded to complete the questionnaires via text, email, or 
phone calls.    
  
  
Coming to HOEC   
  
The Home Economics (HOEC) building is located on the University of Arkansas, Fayetteville 
campus. The study office is located on the 3rd floor of HOEC in 205D.   
  
Supplement  
  
The Multivitamin-Mineral Supplement that we are using in this study was formulated to contain 
selective nutrients such as B vitamins, vitamin C, calcium, magnesium, and zinc and no 
additional compounds such as herbals. The composition of MVM supplement is given in the 
table below. We will randomly assign you either to an MVM supplement group or a placebo 
group. You will be asked to take two pills at a time each day. For research purposes, we will 
make both the supplement and placebo pills look exactly the same and you will not know 
whether you are taking MVM pills or placebo pills.   
  
Supplement packets can be picked up from the study laboratory every Tuesday. Please bring 
back the empty supplement packs from the week prior when you pick up the new pack for the 
next week.  
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Vitamin/Mineral  Amount in 
Supplement  
RDA  %RDA  
B1 = Thiamin  15 mg  1.1 – 1.2 mg  1364  
B2 = Riboflavin  15 mg  1.1 – 1.3 mg  1364  
B3 = Nicotinamide  50 mg  14 – 16 mg  357  
B5 = Pantothenic Acid  23 mg  5 mg  460  
B6  10 mg  1.3 mg  769  
B12  10 µg  2.4 µg  416  
C  500 mg  75 – 90 µg  667  
H = Biotin  150 µg  30 µg  500  
Folic Acid  400 µg  400 µg  100  
Calcium  100 mg  1,000 mg  10  
Magnesium  100 mg  310 – 400 mg  32  
Zinc  10 mg  8 – 11 mg  125  
  
  
Questionnaires  
  
You will be asked to complete questionnaire-I and questionnaire-II on each of the five 
assessment days. In addition, you will be asked to complete one time questionnaires on 
demographics and alcohol consumption at the start of the study.   
  
Demographics:   
A demographic questionnaire will ask about age, gender/sex, year and full or part time in 
college, socioeconomic status and work status, geographic location (urban vs. rural), food 
insecurity, Greek life engagement, general eating behaviors, and sleep behaviors.  
  
Alcohol Use:  
Participants will complete 6 questions from National Institute on Alcohol Abuse and Alcoholism 
(NIAAA) on frequency of drinking and binge drinking behaviors.   
  
Questionnaire-I:   
  
Questionnaire-I is a compilation of several mini questionnaires to assess psychological 
functioning, weight related functioning and health measures.  
  
1). Psychological Functioning Measures:   
  
BAI (Beck Anxiety Inventory): The BAI evaluates physiological and cognitive symptoms of 
anxiety.   
  
Center for Epidemiologic Studies Depression Scale (CES-D): The CES-D is a brief assessment 
measuring attitudes and symptoms of depression.   
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 Self-Esteem: A single item measures self-esteem or your feelings about yourself.   
  
ADI (Abbreviated Dysregulation Inventory): The ADI evaluates ability to control thoughts, 
feelings, and behavior.     
  
PSS (Perceived Stress Scale): The PSS assesses feelings and thoughts related to stress and 
coping.   
  
2). Weight-Related Functioning Measures:  
  
IWQOL-Lite (Impact of Weight on Quality of Life-Lite): The IWQOL-Lite assesses the impact 
of obesity on quality of life in areas of physical functioning, self-esteem, public distress, and 
work.   
  
BSQ (Body Shape Questionnaire): The BSQ measures individuals’ self-perception 
of their body shape and body satisfaction/dissatisfaction.   
  
3). Health Measures:   
  
HRQOL (CDC Health Related Quality of Life-14 Measure): The HRQOL is a measure 
developed by the Centers for Disease Control to assess health related to physical, 
emotional, and social functioning.  
  
IPAQ (International Physical Activity Questionnaire): The IPAQ measures health-related 
physical activity.   
  
Questionnaire-II:  
  
ASA24® (Automated Self-Administered 24-Hour Dietary Assessment Tool): The ASA24® was 
developed by the National Cancer Institute and assesses what was eaten over the previous 24-
hour period.   
  
  
  
  
  
  
  
  
  
 
 
 
 43 
Detailed Schedule of Study Activities  
Day  Date  Instructions  Complete  
Consent    Agree to participate in study; 
measurements taken; complete 
questionnaires  
Questionnaire I  
Questionnaire II  
Day 0    Pick up supplements from study lab    
Day 1    Begin taking the supplement in the 
morning   
  
Day 3    Complete the online questionnaires within 
3 hours of taking the supplement  
Questionnaire I  
Questionnaire II  
Day 4    Complete the online 
questionnaires before taking 
the supplement  
Questionnaire I  
Questionnaire II  
Day 7    Return to the study lab for another week’s 
supply of the supplement & return any 
unused supplements  
  
Day 14    Return to the study lab for another week’s 
supply of the supplement & return any 
unused supplements  
  
Day 15    Complete the online questionnaires within 
3 hours of taking the supplement  
Questionnaire I  
Questionnaire II  
Day 21    Return to the study lab for another week’s 
supply of the supplement & return any 
unused supplements  
  
Day 30    Complete the online questionnaires within 
3 hours of taking the supplement  
Questionnaire I  
Questionnaire II  
Day 31    Return to the study lab to finish out the 
study & return any unused supplements  
  
• Take 2 pills at a time every day throughout the study period  
• Avoid herbal supplements, herbal teas and other vitamin-mineral supplements during the study 
period  
 
Things to Avoid During the Study  
  
You will be asked not to take any other vitamin, mineral and herbal supplements and teas as 
well as herbal teas during the study. You should let us know if a medication is started for a 
mental or physical health-related diagnosis any time during the study.  
  
Compensation  
  
Thank you for your interest in participating in the Multivitamin-Mineral Supplementation & 
Mood Study. You will receive a total of $100 in cash as a stipend to compensate you for your 
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time, effort, and inconvenience related to completing the study. This stipend will be distributed 
incrementally as assessments are completed. Cash is received for each day the online 
questionnaires are completed. Amounts increase for each questionnaire day (Day 1 = $10, Day 
3 = $15, Day 4 = $20, Day 15 = $25, Day 31 = $30). Stipends can be picked up from the 
study laboratory on Day 7, Day 21, and Day 31.   
  
Questions and Contact Information  
  
If you have any questions at any time, you can contact the study coordinator, 
Ryan Grant at 479-575-7538. The researchers conducting this study are Jen Becnel, PhD and 
Sabrina Trudo, PhD, RD. If you have any questions for them, you can contact Dr. Becnel at 479-
575-2358 and Dr. Trudo at 479-575-4863. If you have any questions or concerns about your 
rights as a research participant, then you are encouraged to contact Ro Windwalker at 479-575-
2208.   
  
Services Available for Discomfort Experienced during the Questionnaire  
  
The online questionnaires that you are asked to take ask questions regarding depression, 
anxiety, and how you feel about yourself. If you experience any discomfort while answering 
these questions, please do not hesitate to contact Counseling and Psychological Services (CAPS) 
here on campus at 479.575.5276.   
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Appendix E 
 
Demographic Baseline Questionnaire.  
 
This is the complete questionnaire participants took at baseline. A slightly modified version was 
completed on the final day of participation which excluded the following blocks: demographics, 
parent education, food insecurity, sleep, alcohol, and eating behavior. 
 
MVM Demographics 
Q19 Welcome to the Multivitamin-Mineral Supplementation study! 
  
This study is investigating multivitamin-mineral supplementation and mood. We would 
appreciate you taking about 15 minutes to complete the following survey. Be assured that all 
answers you provide will be kept in the strictest confidentiality. Any personal information 
obtained is for linking participants across surveys and will not be shared. Please click the red 
arrow button to begin. 
 
Q21 What is your first and last name? 
 
Q3 What is your age in years? 
Skip To: End of Survey If Condition: What is your age in years? Is Greater Than 25. Skip To: End of Survey. 
Skip To: End of Survey If Condition: What is your age in years? Is Less Than 18. Skip To: End of Survey. 
Q5 What is your gender? 
o Male  (1)  
o Female  (2)  
o Other  (3)  
 
Q9 Are you a full-time or part-time student? 
o Full-time  (1)  
o Part-time  (2)  
o Not a student  (3)  
 
Skip To: Q11 If Are you a full-time or part-time student? = Not a student 
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Q7 What year are you in college? 
o Freshman  (1)  
o Sophomore  (2)  
o Junior  (3)  
o Senior  (4)  
o Graduate Student  (5)  
o Not a college student  (6)  
 
 
Q11 What is your highest level of education completed? 
o Some high school  (1)  
o High school  (2)  
o Some college  (3)  
o Associate's degree  (4)  
o Bachelor's degree  (5)  
o Post graduate degree  (6)  
 
Q13 What is your employment status? 
o Full-time  (1)  
o Part-time  (2)  
o Unemployed  (3)  
Q15 What is your geographic living location? 
o Urban  (1)  
o Rural  (2)  
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Q17 Are you currently or were you ever involved in Greek life? 
o Yes  (1)  
o No  (2)  
Q12 What is the highest level of education your mother completed? 
o 8th grade or less  (1)  
o Some high school  (2)  
o High school degree  (3)  
o Completed vocational/technical training  (4)  
o Some college  (5)  
o College degree (bachelor's)  (6)  
o Some graduate school  (7)  
o Completed master's or doctoral degree  (8)  
 
Q14 What is the highest level of education your father completed? 
o 8th grade or less  (1)  
o Some high school  (2)  
o High school degree  (3)  
o Completed vocational/technical training  (4)  
o Some college  (5)  
o College degree (bachelor's)  (6)  
o Some graduate school  (7)  
o Completed master's or doctoral degree  (8)  
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Q16 In the last 12 months, the food that I/we bought just didn't last, and I/we didn't have 
money to get more. 
o Often True  (1)  
o Sometimes True  (2)  
o Never True  (3)  
o Don't Know  (4)  
 
Q18 In the last 12 months, I/We couldn't afford to eat balanced meals. 
o Often True  (1)  
o Sometimes True  (2)  
o Never True  (3)  
o Don't know  (4)  
 
Q22 In the last 12 months, did you ever eat less than you felt you should because there wasn't 
enough money for food? 
o Yes  (1)  
o No  (2)  
o Don't know  (3)  
 
Q20 In the last 12 months, were you ever hungry but didn't eat because there wasn't enough 
money for food? 
o Yes  (1)  
o No  (2)  
o Don't know  (3)  
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Q21 In the last 12 months, did you or other adults in your household ever cut the size of your 
meals or skip meals because there wasn't enough money for food? 
o Yes  (1)  
o No  (2)  
o Don't know  (3)  
 
Skip To: End of Block If In the last 12 months, did you or other adults in your household ever cut the size of your 
meals... = No 
Skip To: End of Block If In the last 12 months, did you or other adults in your household ever cut the size of your 
meals... = Don't know 
 
 
Q23 How often in the last 12 months did you or other adults in your household ever cut the size 
of your meals or skip meals because there wasn't enough money for food?  
o Almost every month  (1)  
o Some months but not every month  (2)  
o Only 1 or 2 months  (3)  
o Don't know  (4)  
 
 
Q61 During the past month when have you usually gone to bed? 
________________________________________________________________ 
 
Q62 During the past month how long (in minutes) has it taken you to fall asleep each night? 
▼ 5 minutes (2) ... 60 minutes or more (13) 
 
Q63 During the past month, what time have you usually gotten up in the morning? 
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Q64 The following questions relate to your usual sleep habits during the past month only. 
Please indicate the most accurate reply for the majority of days and night in the past month.  
o How many hours of actual sleep did you get at night?  (1) 
________________________________________________ 
o How many hours were you in bed?  (2) 
________________________________________________ 
 
Q65  
During the past month, how often have you had trouble sleeping because you:  
 Not during the past month (1) 
Less than once a 
week (2) 
Once or twice a 
week (3) 
Three or more 
times a week (4) 
Cannot get to 
sleep within 30 
minutes (2)  o  o  o  o  
Wake up in the 
middle of the 
night or early 
morning (3)  
o  o  o  o  
Have to get up to 
use the bathroom 
(4)  o  o  o  o  
Cannot breathe 
comfortably (5)  o  o  o  o  
Cough or snore 
loudly (6)  o  o  o  o  
Feel too cold (7)  o  o  o  o  
Feel too hot (8)  o  o  o  o  
Have bad dreams 
(9)  o  o  o  o  
Have pain (10)  o  o  o  o  
Other reason (11)  o  o  o  o  
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Q66 During the past month, how often have you taken medicine (prescribed or "over the 
counter") to help you sleep? 
o Not during the past month  (1)  
o Less than once a week  (2)  
o Once or twice a week  (3)  
o Three or more times a week  (4)  
 
Q67 During the past month, how often have you had trouble staying awake while driving, 
eating meals, or engaging in social activity? 
o Not during the past month  (1)  
o Less than once a week  (2)  
o Once or twice a week  (3)  
o Three or more times a week  (4)  
 
Q68 During the past month, how much of a problem has it been for you to keep up enthusiasm 
to get things done?  
o Not during the past month  (1)  
o Less than once a week  (2)  
o Once or twice a week  (3)  
o Three or more times a week  (4)  
Q69 During the past month, how would you rate your sleep quality overall? 
o Very good  (1)  
o Fairly good  (2)  
o Fairly bad  (3)  
o Very bad  (4)  
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Q20 During the last 12 months, how often did you usually have any kind of drink containing 
alcohol? By a drink we mean half an ounce of absolute alcohol (e.g. a 12oz can or glass of beer 
or cooler, a 5oz glass of wine, or a drink containing 1 shot of liquor). Choose only one.  
o Every day  (1)  
o 5 to 6 times a week  (2)  
o 3 to 4 times a week  (3)  
o Twice a week  (4)  
o Once a week  (5)  
o 2 to 3 times a month  (6)  
o Once a month  (7)  
o 3 to 11 times in the past year  (8)  
o 1 or 2 times in the past year  (9)  
o I did not drink any alcohol in the past year, but I did drink in the past  (10)  
o I have never drank any alcohol in my life  (11)  
 
Skip To: Q22 If During the last 12 months, how often did you usually have any kind of drink containing alcohol? B... 
= I did not drink any alcohol in the past year, but I did drink in the past 
Skip To: Q24 If During the last 12 months, how often did you usually have any kind of drink containing alcohol? B... 
= I have never drank any alcohol in my life 
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Q26 During the last 12 months, how many alcoholic drinks did you have on a typical day when 
you drank alcohol? 
o 25 or more drinks  (1)  
o 19 to 24 drinks  (2)  
o 16 to 18 drinks  (3)  
o 12 to 15 drinks  (4)  
o 9 to 11 drinks  (5)  
o 7 to 8 drinks  (6)  
o 5 to 6 drinks  (7)  
o 3 to 4 drinks  (8)  
o 2 drinks  (9)  
o 1 drink  (10) 
 
Q28 During the last 12 months, what is the largest number of drinks containing alcohol that you 
drank within a 24-hour period? 
o 36 drinks or more  (1)  
o 24 to 35 drinks  (2)  
o 18 to 23 drinks  (3)  
o 12 to 17 drinks  (4)  
o 8 to 11 drinks  (5)  
o 5 to 7 drinks  (6)  
o 4 drinks  (7)  
o 3 drinks  (8)  
 
 54 
2 drinks  (9)  
o 1 drink  (10)  
 
Q30 During the last 12 months, how often did you drink this largest number of drinks? Choose 
only one.  
o Every day  (1)  
o 5 to 6 times a week  (2)  
o 3 to 4 times a week  (3)  
o Twice a week  (4)  
o Once a week  (5)  
o 2 to 3 times a month  (6)  
o Once a month  (7)  
o 3 to 11 times in the past year  (8)  
o 1 or 2 times in the past year  (9)  
 
Q32 During the last 12 months, how often did you have 5 or more (males) or 4 or more 
(females) drinks containing any kind of alcohol within a two-hour period? (That would be the 
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equivalent of at least 5 (4) 12oz cans or bottles of beer, 5 (4) 5oz glasses of wine, 5 (4) drinks 
each containing once shot of liquor or spirits.) Choose only one response. 
o Every day  (1)  
o 5 to 6 days a week  (2)  
o 3 to 4 days a week  (3)  
o Two days a week  (4)  
o One day a week  (5)  
o 2 to 3 days a month  (6)  
o One day a month  (7)  
o 3 to 11 days in the past year  (8)  
o 1 or 2 days in the past year  (9)  
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more (females) 
drinks... = Every day 
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more (females) 
drinks... = 5 to 6 days a week 
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more (females) 
drinks... = 3 to 4 days a week 
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more (females) 
drinks... = Two days a week 
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more (females) 
drinks... = One day a week 
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more (females) 
drinks... = 2 to 3 days a month 
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more (females) 
drinks... = One day a month 
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more (females) 
drinks... = 3 to 11 days in the past year 
Skip To: End of Block If During the last 12 months, how often did you have 5 or more (males) or 4 or more (females) 
drinks... = 1 or 2 days in the past year 
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Q24 So you have never had a drink containing alcohol in your entire life. 
o Correct, I have never drank  (1)  
o No, I did drink  (2)  
 
Skip To: Q22 If So you have never had a drink containing alcohol in your entire life. = No, I did drink 
Skip To: End of Block If So you have never had a drink containing alcohol in your entire life. = Correct, I have never 
drank 
Q22 During your lifetime, what is the maximum number of drinks containing alcohol that you 
drank within a 24-hour period? 
o 36 drinks or more  (1)  
o 24 to 35 drinks  (2)  
o 18 to 23 drinks  (3)  
o 12 to 17 drinks  (4)  
o 8 to 11 drinks  (5)  
o 5 to 7 drinks  (6)  
o 4 drinks  (7)  
o 3 drinks  (8)  
o 2 drinks  (9)  
o 1 drink  (10)  
 
Q29 During the past 6 months, have you had times when you eat continuously during the day 
or parts of the day without planning what and how much you would eat? 
o Yes  (1)  
o No  (2)  
 
Skip To: Q27 If During the past 6 months, have you had times when you eat continuously during the day or parts 
of... = Yes 
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Q27 Did you experience a loss of control, that is, you felt like you could not control your eating? 
o Yes  (1)  
o No  (2)  
Q39 In the past 3 months, have you had any episodes of binge eating?  
o Yes  (1)  
o Maybe  (2)  
o No  (3)  
Q38 During the past 3 months, how often did you keep eating a meal even though you were not 
hungry anymore? 
o Never  (1)  
o Rarely (one per month or less)  (2)  
o Occasionally (once per week)  (3)  
o Most of the time (multiple times per week)  (4)  
Q31 In the past 3 months, how often did you keep eating a meal even though you felt full? 
o Never  (1)  
o Rarely (once per month or less)  (2)  
o Occasionally (once per week or more)  (3)  
o Most of the time (multiple times per week)  (4)  
Q33 During the past 3 months, how much of your daily food intake did you consume after 
suppertime? 
o 0 (none)  (1)  
o 1-25% (up to a quarter)  (2)  
o 26-50% (about half)  (3)  
o 51-75% (more than half)  (4)  
76-100% (almost all)  (5)  
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Q35 During the past 3 months, how often did you get up (at least once) in the middle of the 
night other than [having] to use the bathroom? 
o Never  (1)  
o Less than once a week  (2)  
o About once a week  (3)  
o More than once a week  (4)  
o Every night  (5)  
Q37 During the past 3 months, how often would you have a snack in the middle of the night? 
o Never  (1)  
o Sometimes  (2)  
o About half the time  (3)  
o Usually  (4)  
o Always  (5) 
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Q41 Below is a list 
of common 
symptoms of 
anxiety. Please 
carefully read 
each item in the 
list. Indicate how 
much you have 
been bothered by 
that symptom 
during the past 
week, including 
today.  
 
Not at all (1) 
Mildly, but it 
didn't bother me 
much (2) 
Moderately- it 
wasn't pleasant at 
times (3) 
Severely- it 
bothered me a lot 
(4) 
Numbness or 
Tingling (1)  o  o  o  o  
Feeling hot (2)  o  o  o  o  
Wobbliness in legs 
(3)  o  o  o  o  
Unable to Relax 
(4)  o  o  o  o  
Fear of worst 
happening (5)  o  o  o  o  
Dizzy or 
lightheaded (6)  o  o  o  o  
Heart 
pounding/racing 
(7)  o  o  o  o  
Unsteady (8)  o  o  o  o  
Terrified or afraid 
(9)  o  o  o  o  
Nervous (10)  o  o  o  o  
Feeling of choking 
(11)  o  o  o  o  
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Hands trembling 
(12)  o  o  o  o  
Shaky/unsteady 
(13)  o  o  o  o  
Fear of losing 
control (14)  o  o  o  o  
Difficulty in 
breathing (15)  o  o  o  o  
Fear of dying (16)  o  o  o  o  
Scared (17)  o  o  o  o  
Indigestion (18)  o  o  o  o  
Faint/lightheaded 
(19)  o  o  o  o  
Face flushed (20)  o  o  o  o  
Hot/cold sweats 
(21)  o  o  o  o  
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Q43 Below is a list of ways you might have felt or behaved. Please indicate how often you have 
felt this way during the last week. 
 
Rarely or none of 
the time (less 
than 1 day) (1) 
Some or a little of 
the time (1-2 
days) (2) 
Occasionally or a 
moderate amount 
of time (3-4 days) 
(3) 
All of the time (5-
7 days) (4) 
I was bothered by 
things that usually 
don't bother me. 
(1)  
o  o  o  o  
I had trouble 
keeping my mind 
on what I was 
doing. (2)  
o  o  o  o  
I felt depressed. 
(3)  o  o  o  o  
I felt that 
everything I did 
was an effort. (4)  o  o  o  o  
I felt hopeful 
about the future. 
(5)  o  o  o  o  
I felt fearful. (6)  o  o  o  o  
My sleep was 
restless. (7)  o  o  o  o  
I was happy. (8)  o  o  o  o  
I felt lonely. (9)  o  o  o  o  
I could not "get 
going." (10)  o  o  o  o  
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Q45 I have high self-esteem 
o Strongly Agree  (1)  
o Agree  (2)  
o Neutral  (3)  
o Disagree  (4)  
o Strongly disagree  (5)  
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Q47 Below is a 
series of 
statements. 
Indicate how often 
they are true of you 
by choosing the 
option that best 
describes you. 
Never true (1) Occasionally true (2) Mostly true (3) 
Always 
true (4) 
I have difficulty 
remaining seated at 
school or at home 
during dinner. (1)  
o  o  o  o  
I get very fidgety 
after a few minutes 
if I am supposed to 
sit still. (2)  
o  o  o  o  
I have difficulty 
keeping attention 
on tasks. (3)  o  o  o  o  
I get into 
arguments when 
people disagree 
with me. (4)  
o  o  o  o  
Little things or 
distractions throw 
me off. (5)  o  o  o  o  
I can’t seem to stop 
moving. (6)  o  o  o  o  
Most of the time I 
don't pay attention 
to what I am doing. 
(7)  
o  o  o  o  
I get bored easily. 
(8)  o  o  o  o  
I am easily 
distracted. (9)  o  o  o  o  
I spend money 
without thinking 
about it first. (10)  o  o  o  o  
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Q49 Below is a series of statements. Indicate how often they are true of you by choosing the 
option that best describes you. 
 Never true (1) Occasionally true (2) Mostly true (3) Always true (4) 
I develop a plan 
for all my 
important goals. 
(1)  
o  o  o  o  
I put my plans into 
action. (2)  o  o  o  o  
I think about the 
future 
consequences of 
my actions. (3)  
o  o  o  o  
Once I have a goal 
I make a plan to 
reach it. (4)  o  o  o  o  
As soon as I see 
things are not 
working, I do 
something about 
it. (5)  
o  o  o  o  
I consider what 
will happen 
before I make a 
plan. (6)  
o  o  o  o  
I think about my 
mistakes to make 
sure they don't 
happen again. (7)  
o  o  o  o  
I spend time 
thinking about 
how to reach my 
goals. (8)  
o  o  o  o  
Failure at a task or 
in school makes 
me work harder. 
(9)  
o  o  o  o  
I stick to a task 
until it is finished. 
(10)  o  o  o  o  
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Q51 Below is a series of statements. Indicate how often they are true of you by choosing the 
option that best describes you. 
 Never True (1) Occasionally True (2) Mostly True (3) Always True (4) 
I have trouble 
controlling my 
temper. (1)  o  o  o  o  
I lose sleep 
because I worry. 
(2)  o  o  o  o  
When I am angry I 
lose control over 
my actions. (3)  o  o  o  o  
I get so frustrated 
that I often feel 
like a "bomb 
ready to explode." 
(4)  
o  o  o  o  
I "fly off the 
handle" for no 
good reason. (5)  o  o  o  o  
There are days 
when I'm "on 
edge" all the time. 
(6)  
o  o  o  o  
I easily become 
emotionally upset 
when I am tired. 
(7)  
o  o  o  o  
Often I am afraid I 
will lose control of 
my feelings. (8)  o  o  o  o  
I slam doors when 
I am mad. (9)  o  o  o  o  
My mood goes up 
and down without 
reason. (10)  o  o  o  o  
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Q52 The 
questions in 
this scale ask 
you about 
your feelings 
and thoughts 
during the last 
week. In each 
case, you will 
be asked to 
indicate how 
often you felt 
or thought a 
certain way.  
 
Never (1) Almost Never (2) Sometimes (3) 
Fairly Often 
(4) Very Often (5) 
How often 
have you been 
upset because 
of something 
that happened 
unexpectedly? 
(1)  
o  o  o  o  o  
How often 
have you felt 
that you were 
unable to 
control the 
important 
things in your 
life? (2)  
o  o  o  o  o  
How often 
have you felt 
nervous and 
“stressed”? (3)  
o  o  o  o  o  
How often 
have you felt 
confident 
about your 
ability to 
handle your 
personal 
problems? (4)  
o  o  o  o  o  
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How often 
have you felt 
that things 
were going 
your way? (5)  
o  o  o  o  o  
How often 
have you 
found that you 
could not cope 
with all the 
things that you 
had to do? (6)  
o  o  o  o  o  
How often 
have you been 
able to control 
irritations in 
your life? (7)  
o  o  o  o  o  
How often 
have you felt 
that you were 
on top of 
things? (8)  
o  o  o  o  o  
How often 
have you been 
angered 
because of 
things that 
were outside 
of your 
control? (9)  
o  o  o  o  o  
How often 
have you felt 
difficulties 
were piling up 
so high that 
you could not 
overcome 
them? (10)  
o  o  o  o  o  
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Q54 Would you say that in general your health is 
o Excellent  (1)  
o Very good  (2)  
o Good  (3)  
o Fair  (4)  
o Poor  (5)  
o Don't know/Not sure  (6)  
 
Q56 Now thinking about your physical health, which includes physical illness and injury, for how 
many days during the past 30 days was your physical health not good? 
 0 3 6 9 12 15 18 21 24 27 30 
 
Number of days () 
 
 
Q58 Now thinking about your mental health, which includes stress, depression, and problems 
with emotions, for how many days during the past 30 days was your mental health not good? 
 0 3 6 9 12 15 18 21 24 27 30 
 
Number of days () 
 
 
Q60 During the past 30 days, for about how many days did poor physical or mental health keep 
you from doing your usual activities, such as self-care, work, or recreation? 
 0 3 6 9 12 15 18 21 24 27 30 
 
Number of days () 
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Q62 Are you LIMITED in any way in any activities because of any impairment or health 
problem? 
o Yes  (1)  
o No  (2)  
o Don't know/Not sure  (3)  
 
Skip To: End of Block If Are you LIMITED in any way in any activities because of any impairment or health problem? 
= No 
 
Q64 For HOW LONG have your activities been limited because of your major impairment or 
health problem? 
o Days  (1)  
o Weeks  (2)  
o Months  (3)  
o Years  (4)  
o Don't know/not sure  (5)  
 
Q66 Because of any impairment or health problem, do you need the help of other persons with 
your PERSONAL CARE needs, such as eating, bathing, dressing, or getting around the house? 
o Yes  (1)  
o No  (2)  
o Don't know/not sure  (3)  
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Q68 Because of any impairment or health problem, do you need the help of other persons in 
handling your ROUTINE needs, such as everyday household chores, doing necessary business, 
shopping, or getting around for other purposes? 
o Yes  (1)  
o No  (2)  
o Don't know/not sure  (3)  
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Q70 Over the 
last week, how 
true are the 
following 
statements: 
 
Never true (1) Rarely true (2) Occasionally true (3) Often true (4) 
Always true 
(5) 
Because of my 
weight, I have 
trouble picking 
up objects. (1)  
o  o  o  o  o  
Because of my 
weight, I have 
trouble tying 
my shoes. (2)  
o  o  o  o  o  
Because of my 
weight, I have 
difficulty 
getting up 
from chairs. 
(3)  
o  o  o  o  o  
Because of my 
weight, I have 
trouble using 
stairs. (4)  
o  o  o  o  o  
Because of my 
weight, I have 
difficulty 
putting on or 
taking off my 
clothing. (5)  
o  o  o  o  o  
Because of my 
weight, I have 
trouble with 
mobility. (6)  
o  o  o  o  o  
Because of my 
weight, I have 
trouble 
crossing my 
legs. (7)  
o  o  o  o  o  
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I feel short of 
breath with 
only mild 
exertion. (8)  
o  o  o  o  o  
I am troubled 
by painful or 
stiff joints. (9)  o  o  o  o  o  
My ankles and 
lower legs are 
swollen at the 
end of the day. 
(10)  
o  o  o  o  o  
I am worried 
about my 
health. (11)  o  o  o  o  o  
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Q72 Over the 
last week, how 
true are the 
following 
statements: 
 
 
Never true (1) Rarely true (2) Occasionally true (3) Often true (4) 
Always true 
(5) 
Because of my 
weight, I am 
self-conscious. 
(1)  
o  o  o  o  o  
Because of my 
weight, my 
self-esteem is 
not what it 
could be. (2)  
o  o  o  o  o  
Because of my 
weight, I feel 
unsure of 
myself. (3)  
o  o  o  o  o  
Because of my 
weight, I don't 
like myself. (4)  o  o  o  o  o  
Because of my 
weight, I am 
afraid of being 
rejected. (5)  
o  o  o  o  o  
Because of my 
weight, I avoid 
looking in 
mirrors or 
seeing myself 
in 
photographs. 
(6)  
o  o  o  o  o  
Because of my 
weight, I am 
embarrassed 
to be seen in 
public places. 
(7)  
o  o  o  o  o  
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Because of my 
weight, I do 
not enjoy 
sexual activity. 
(8)  
o  o  o  o  o  
Because of my 
weight, I have 
little or no 
sexual desire. 
(9)  
o  o  o  o  o  
Because of my 
weight, I have 
difficulty with 
sexual 
performance. 
(10)  
o  o  o  o  o  
Because of my 
weight, I avoid 
sexual 
encounters 
whenever 
possible. (11)  
o  o  o  o  o  
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Q74 Over the 
last week, how 
true are the 
following 
statements: 
 
 
 
 
 
Never true (1) Rarely true (2) Occasionally true (3) 
Usually true 
(4) 
Always true 
(5) 
Because of my 
weight, I worry 
about fitting 
into seats in 
public places 
(e.g., theaters, 
restaurants, 
cars, 
airplanes). (1)  
o  o  o  o  o  
Because of my 
weight, I worry 
about fitting 
through aisles 
or turnstiles. 
(2)  
o  o  o  o  o  
Because of my 
weight, I worry 
about finding 
chairs that are 
strong enough 
to hold my 
weight. (3)  
o  o  o  o  o  
Because of my 
weight, I 
experience 
ridicule, 
teasing, or 
unwanted 
attention. (4)  
o  o  o  o  o  
Because of my 
weight, I 
experience 
discrimination 
by others. (5)  
o  o  o  o  o  
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Because of my 
weight, I have 
trouble getting 
things 
accomplished 
or meeting my 
responsibilities. 
(6)  
o  o  o  o  o  
Because of my 
weight, I am 
less productive 
than I could be. 
(7)  
o  o  o  o  o  
Because of my 
weight, I don’t 
receive 
appropriate 
raises, 
promotions, or 
recognition at 
work. (8)  
o  o  o  o  o  
Because of my 
weight, I am 
afraid to go on 
job interviews 
(9)  
o  o  o  o  o  
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Q76 Over the past FOUR WEEKS: 
 Never (1) Rarely (2) Sometimes (3) Often (4) 
Very Often 
(5) Always (6) 
Has feeling 
bored made 
you worry 
or agonize 
about your 
shape? (1)  
o  o  o  o  o  o  
Have you 
thought 
that your 
thighs, hips 
or bottom 
are too 
large for the 
rest of you? 
(2)  
o  o  o  o  o  o  
Have you 
felt so bad 
about your 
shape that 
you have 
cried? (3)  
o  o  o  o  o  o  
Have you 
avoided 
running 
because 
your flesh 
might 
wobble? (4)  
o  o  o  o  o  o  
Has being 
with thin 
people 
made you 
feel self-
conscious 
about your 
shape? (5)  
o  o  o  o  o  o  
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Q78 During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, 
digging, aerobics, or fast bicycling? 
▼ 0 (1) ... 7 (8) 
Q80 How much time did you usually spend doing vigorous physical activities on one of those 
days? 
o Hours per day  (1) ________________________________________________ 
o Minutes per day  (2) ________________________________________________ 
 
Q82 During the last 7 days, on how many days did you do moderate physical activities like 
carrying light loads, bicycling at a regular pace, or doubles tennis? Do not include walking. 
▼ 0 (1) ... 7 (8) 
 
Have you 
worried 
about your 
thighs 
spreading 
out when 
sitting 
down? (6)  
o  o  o  o  o  o  
Has eating 
sweets, 
cakes, or 
other high 
calorie food 
made you 
feel fat? (7)  
o  o  o  o  o  o  
Has worry 
about your 
shape made 
you feel you 
ought to 
exercise? 
(8)  
o  o  o  o  o  o  
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Q84 How much time did you usually spend doing moderate physical activities on one of those 
days? 
o Hours per day  (1) ________________________________________________ 
o Minutes per day  (2) ________________________________________________ 
 
Q86 During the last 7 days, on how many days did you walk for at least 10 minutes at a time? 
▼ 0 (1) ... 7 (8) 
Q88 How much time did you usually spend walking on one of those days? 
o Hours per day  (1) ________________________________________________ 
o Minutes per day  (2) ________________________________________________ 
 
Q90 During the last 7 days, how much time did you spend sitting on a week day? 
o Hours per day  (1) ________________________________________________ 
o Minutes per day  (2) ______________________________________________  
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Appendix F 
 
IRB Approval Letter 
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